Gilead Sciences Inc.
GILD · Large Cap · NASDAQ · Healthcare · Drug Manufacturers - General
$156.09−$1.10 (-0.70%)
Market closed · opens in 2d 2hNext open: Monday, Oct 26, 9:30 AM ETFree AI brief
Get the full brief on GILD
Free to track. No card required. Usually ready in 10-15 minutes.
Where GILD sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$107.75
High$157.29
Today $156.09
RSI (14)
66.0Neutral
03070100
Stocksbrew score
73/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Lowest
$126
Current price
$156.09
Median target
$165
Highest
$180
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Forward P/E
Favorable · 30% below avg
17.01x
Price / FCF
Strong · Cash flow supports price
14.96x
ROIC
Strong · Excellent capital returns
34.4%
ROE
Favorable · 43.2% - strong capital efficiency
-20.7%
How it stacks up against its peers
GILD against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $193.67B | 18.1 | +5.5% | 73 |
 | $10.30B | 19.6 | +19.7% | 78 |
 | $32.47B | 34.0 | +15.5% | 78 |
 | $3.83B | 11.5 | +13.5% | 78 |
 | $1.18T | 42.7 | +49.6% | 77 |